Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 42 Recruiting 37 Completed 7 Withdrawn 4 Not yet recruiting 4 Suspended 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 8 Carboplatin 7 Pemetrexed 5 Nivolumab 5 Cyclophosphamide 5 Cisplatin 5 ixazomib 4 durvalumab 4 Specimen Handling 4 Paclitaxel 4 Bevacizumab 4 ibrutinib 3 fludarabine phosphate 3 fludarabine 3 Ipilimumab 3 Gemcitabine 3 Docetaxel 3 Cetuximab 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2 tislelizumab 2 temsirolimus 2 evolocumab 2 enzalutamide 2 daratumumab 2 atezolizumab 2 Trastuzumab 2 Tomography, X-Ray Computed 2 Standard of Care 2 Sirolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Radiation × 30 days × Clear all

NCT03337698 2026-05-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Terminated

314 enrolled 31 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡